Prevalence and risk factors for hepatocellular carcinoma in individuals with haemophilia in the era of direct-acting antiviral agents: A national inpatient sample study.
Xi YangKwonho JeongJonathan G YabesMargaret V RagniPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)
From 2016 to 2018, HCC rates did not change significantly in haemophilia discharges. NASH, HCV, and CCI are significant risks for HCC in haemophilia during the DAA-era.